Chembio Diagnostics and Takeda Pharmaceutical Complete Feasibility Study
March 11, 2020 16:10 ET
|
Chembio Diagnostics, Inc.
MEDFORD, N.Y., March 11, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced that it...
Chembio Diagnostics to Report Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020
March 03, 2020 17:42 ET
|
Chembio Diagnostics, Inc.
MEDFORD, March 03, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will release...
Chembio Diagnostics Provides Update on Regulatory Status of DPP HIV-Syphilis System
March 03, 2020 08:30 ET
|
Chembio Diagnostics, Inc.
MEDFORD, N.Y., March 03, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, is providing an update on the...
Chembio Diagnostics Receives $1.5 Million UNICEF Order for Multiplex Zika Systems
February 12, 2020 07:45 ET
|
Chembio Diagnostics, Inc.
MEDFORD, N.Y., Feb. 12, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced a $1.5 million...
Chembio Diagnostics Announces CEO Transition
January 09, 2020 16:05 ET
|
Chembio Diagnostics, Inc.
MEDFORD, N.Y., Jan. 09, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced President and...
Chembio Diagnostics Provides Update on FDA Submission of DPP HIV-Syphilis Test
January 02, 2020 16:05 ET
|
Chembio Diagnostics, Inc.
MEDFORD, N.Y., Jan. 02, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today provided an update on its...
Chembio Diagnostics Completes Acquisition of Orangelife
November 25, 2019 16:30 ET
|
Chembio Diagnostics, Inc.
MEDFORD, N.Y., Nov. 25, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced that it has...
Chembio Diagnostics to Participate in Upcoming Investor Conferences
November 14, 2019 16:40 ET
|
Chembio Diagnostics, Inc.
MEDFORD, N.Y., Nov. 14, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today the company...
Chembio Diagnostics Reports Third Quarter 2019 Financial Results
November 07, 2019 16:05 ET
|
Chembio Diagnostics, Inc.
MEDFORD, N.Y., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial...
Chembio Diagnostics Enters into Definitive Agreement to Acquire Orangelife
November 07, 2019 16:03 ET
|
Chembio Diagnostics, Inc.
Acquisition will expand commercial presence and market opportunity in Brazil MEDFORD, N.Y., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care...